GlaxoSmithKline Consumer Healthcare Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Consumer Healthcare Limited with three other
bakery and confectionary companies in Asia:
Ismail Industries Limited
sales of 30.19 billion Pakistan Rupees [US$193.20 million]
of which 77%
was Food Processing),
Imuraya Group Company Limited
(45.11 billion Japanese Yen [US$412.74 million]
of which 87%
was Distribution Business), and
Nakamuraya Co., Ltd.
based in Japan
(38.74 billion Japanese Yen [US$354.51 million]
of which 76%
was Confectionery Business).
During the year ended March of 2019, sales at
GlaxoSmithKline Consumer Healthcare Limited were 47.82 billion Indian Rupees (US$670.92 million).
increase of 10.8%
versus 2018, when the company's sales were 43.17 billion Indian Rupees.